Rubric Capital Management LP
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 10, 2024), Rubric Capital Management LP reported 67 stock positions worth $3.4 billion. Its top holding was Teva Pharmaceutical-SP ADR (TEVA) at 7.4% of the portfolio, followed by Viatris (VTRS, 6.5%) and Roivant Sciences (ROIV, 6.2%). Compared with Q4 2023, it opened 14 new positions, sold out of 3, added to 22 and reduced 16. The biggest buy was a new position in Vistra (VST) and the biggest sale Collegium Pharmaceutical (COLL, shares −34%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001687509
- Portfolio Value
- $3.4B (Q1 2024)
- SEC Filing
- 0001104659-24-059724 ↗ filed May 10, 2024
Holdings Value
Holdings 67 stocks · $3.4B
| TEVA Teva Pharmaceutical-SP ADR | 7.37% | 17,669,588 | $249.3M | Reduce -3.1% |
| VTRS Viatris Inc. | 6.51% | 18,442,093 | $220.2M | Add +5.0% |
| ROIV Roivant Sciences Ltd. | 6.23% | 20,000,000 | $210.8M | Add +5.3% |
| GLNG Golar LNG Ltd. | 4.63% | 6,506,757 | $156.6M | No change |
| BGC BGC Group Inc. Class A | 4.37% | 19,000,000 | $147.6M | Reduce -5.0% |
| COOP Mr Cooper Group Inc. | 3.50% | 1,518,773 | $118.4M | Reduce -14.9% |
| QDEL Quidelortho Corp. | 3.40% | 2,400,000 | $115.1M | Add +144.9% |
| FLR Fluor Corp. | 3.25% | 2,600,000 | $109.9M | Add +72.2% |
| VST Vistra Corp. | 2.50% | 1,213,998 | $84.6M | New |
| CSTM Constellium SE | 2.37% | 3,630,347 | $80.3M | Add +24.1% |
| PTVE Pactiv Evergreen Inc. | 2.35% | 5,541,393 | $79.4M | Add +9.9% |
| MATV Mativ Holdings Inc. | 2.22% | 4,000,000 | $75.0M | Add +49.1% |
| ARQT Arcutis Biotherapeutics Inc. | 2.20% | 7,510,000 | $74.4M | Add +13.0% |
| HRTX Heron Therapeutics Inc. | 2.19% | 26,713,503 | $74.0M | No change |
| COLL Collegium Pharmaceutical Inc. | 2.11% | 1,834,027 | $71.2M | Reduce -33.5% |
| RNW Renew Energy Global PLC-A | 2.08% | 11,711,700 | $70.3M | Add +12.4% |
| IBIT iShares Bitcoin Trust ETF | 2.06% | 1,722,497 | $69.7M | New |
| ANIP Ani Pharmaceuticals Inc. | 1.96% | 958,533 | $66.3M | Reduce -14.8% |
| LBTYA Liberty Global Ltd. Class A | 1.92% | 3,845,351 | $65.1M | Add +29.1% |
| DOLE Dole PLC | 1.81% | 5,141,388 | $61.3M | Add +13.5% |
| SSYS Stratasys Ltd. | 1.74% | 5,050,000 | $58.7M | Add +18.8% |
| AMRX Amneal Pharmaceuticals Inc. | 1.71% | 9,541,948 | $57.8M | Add +19.3% |
| VYX NCR Voyix Corp. | 1.70% | 4,546,081 | $57.4M | Add +26.6% |
| OFIX Orthofix Medical Inc. | 1.57% | 3,665,000 | $53.2M | No change |
| ADEA Adeia Inc. | 1.50% | 4,640,009 | $50.7M | No change |
| XPER Xperi Inc. | 1.44% | 4,043,744 | $48.8M | Add +58.2% |
| MREO Mereo Biopharma Group PL-ADR | 1.32% | 13,552,997 | $44.7M | No change |
| AIR Aar Corp. | 1.28% | 725,000 | $43.4M | Reduce -19.1% |
| KNSA Kiniksa Pharmaceuticals Ltd. | 1.28% | 2,196,009 | $43.3M | Reduce -24.5% |
| PLYA Playa Hotels & Resorts NV | 1.19% | 4,155,840 | $40.3M | Reduce -6.2% |
| EXTR Extreme Networks Inc. | 1.18% | 3,450,000 | $39.8M | New |
| PLAY Dave & Buster's Entertainmen | 1.11% | 598,503 | $37.5M | New |
| ZYME Zymeworks Inc. | 1.08% | 3,475,384 | $36.6M | No change |
| ATMU Atmus Filtration Technologie | 1.08% | 1,132,056 | $36.5M | New |
| ADPT Adaptive Biotechnologies | 1.00% | 10,500,000 | $33.7M | Add +266.8% |
| LBTYK Liberty Global Ltd. Class C | 0.99% | 1,893,293 | $33.4M | Add +2.2% |
| KOP Koppers Holdings Inc. | 0.93% | 572,658 | $31.6M | Reduce -43.1% |
| TAC Transalta Corp. | 0.89% | 4,687,158 | $30.1M | Reduce -8.9% |
| PARR Par Pacific Holdings Inc. | 0.85% | 772,384 | $28.6M | Reduce -35.6% |
| CNNE Cannae Holdings Inc. | 0.80% | 1,214,217 | $27.0M | Add +234.5% |
| SDGR Schrodinger Inc. | 0.80% | 998,276 | $27.0M | New |
| CAR Avis Budget Group Inc. | 0.78% | 215,092 | $26.3M | New |
| CHRS Coherus Oncology Inc. | 0.73% | 10,400,000 | $24.9M | Add +2531.5% |
| RSKD Riskified Ltd. Class A | 0.67% | 4,173,636 | $22.6M | No change |
| SWTX Springworks Therapeutics Inc. | 0.62% | 426,768 | $21.0M | New |
| FIP Ftai Infrastructure Inc. | 0.59% | 3,193,530 | $20.1M | No change |
| NUVL Nuvalent Inc. Class A | 0.58% | 261,874 | $19.7M | New |
| TRVI Trevi Therapeutics Inc. | 0.57% | 5,564,123 | $19.2M | Reduce -2.1% |
| SCPH Scpharmaceuticals Inc. | 0.52% | 3,525,000 | $17.7M | Add +0.7% |
| OVID Ovid Therapeutics Inc. | 0.48% | 5,315,969 | $16.2M | No change |
| OABI Omniab Inc. | 0.46% | 2,850,588 | $15.5M | No change |
| GDRX Goodrx Holdings Inc. Class A | 0.44% | 2,117,054 | $15.0M | Reduce -64.0% |
| ARDX Ardelyx Inc. | 0.39% | 1,816,585 | $13.3M | Reduce -54.7% |
| RVNC Revance Therapeutics Inc. | 0.39% | 2,656,847 | $13.1M | Add +81.8% |
| CGEM Cullinan Therapeutics Inc. | 0.32% | 626,929 | $10.7M | No change |
| HOWL Werewolf Therapeutics Inc. | 0.31% | 1,621,034 | $10.5M | Reduce -16.2% |
| MD Pediatrix Medical Group Inc. | 0.27% | 908,600 | $9.1M | New |
| TSAT Telesat Corp. | 0.24% | 959,764 | $8.2M | No change |
| MYPS Playstudios Inc. | 0.19% | 2,368,777 | $6.6M | Add +20.8% |
| SPRY Ars Pharmaceuticals Inc. | 0.19% | 639,203 | $6.5M | No change |
| OPK Opko Health Inc. | 0.18% | 4,935,814 | $5.9M | New |
| PTGX Protagonist Therapeutics Inc. | 0.17% | 198,059 | $5.7M | New |
| CRS Carpenter Technology | 0.17% | 78,661 | $5.6M | New |
| BCYC Bicycle Therapeutics PLC-ADR | 0.15% | 205,423 | $5.1M | No change |
| TXMD Therapeuticsmd Inc. | 0.08% | 1,192,191 | $2.7M | No change |
| XERS Xeris Biopharma Holdings Inc. | 0.02% | 310,959 | $687K | New |
| VINCERX PHARMA INC | 0.02% | 116,873 | $591K | Reduce -67.0% |
Other holdings (1): bonds, preferreds, convertibles and warrants · $1.6M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| COHERUS ONCOLOGY INC (CHRS 1.5 04/15/26) | NOTE 1.500% 4/1 · principal | 2,500,000 | $1.6M | Add +400.0% |
Total filed on the 13F, all lines: $3.4B.
Portfolio Sells Q4 2023 → Q1 2024
| COLL Collegium Pharmaceutical Inc. | Reduce -33.5% | 2.11% | −1.06 |
| GDRX Goodrx Holdings Inc. Class A | Reduce -64.0% | 0.44% | −1.02 |
| BGC BGC Group Inc. Class A | Reduce -5.0% | 4.37% | −1.02 |
| KOP Koppers Holdings Inc. | Reduce -43.1% | 0.93% | −0.99 |
| COOP Mr Cooper Group Inc. | Reduce -14.9% | 3.50% | −0.84 |
| AIR Aar Corp. | Reduce -19.1% | 1.28% | −0.80 |
| PARR Par Pacific Holdings Inc. | Reduce -35.6% | 0.85% | −0.78 |
| TAC Transalta Corp. | Reduce -8.9% | 0.89% | −0.70 |
| SILK Silk Road Medical Inc. | Sold out | 0.00% | −0.65 |
| KNSA Kiniksa Pharmaceuticals Ltd. | Reduce -24.5% | 1.28% | −0.62 |
| PCRX Pacira Biosciences Inc. | Sold out | 0.00% | −0.62 |
| ARDX Ardelyx Inc. | Reduce -54.7% | 0.39% | −0.54 |
| STRO Sutro Biopharma Inc. Com SHS | Sold out | 0.00% | −0.54 |
| ANIP Ani Pharmaceuticals Inc. | Reduce -14.8% | 1.96% | −0.35 |
| PLYA Playa Hotels & Resorts NV | Reduce -6.2% | 1.19% | −0.24 |
| VINCERX PHARMA INC | Reduce -67.0% | 0.02% | +0.00 |
| HOWL Werewolf Therapeutics Inc. | Reduce -16.2% | 0.31% | +0.03 |
| TEVA Teva Pharmaceutical-SP ADR | Reduce -3.1% | 7.37% | +0.27 |
| TRVI Trevi Therapeutics Inc. | Reduce -2.1% | 0.57% | +0.28 |
Portfolio Buys Q4 2023 → Q1 2024
| VST Vistra Corp. | New | 2.50% | +2.50 |
| IBIT iShares Bitcoin Trust ETF | New | 2.06% | +2.06 |
| ARQT Arcutis Biotherapeutics Inc. | Add +13.0% | 2.20% | +1.40 |
| EXTR Extreme Networks Inc. | New | 1.18% | +1.18 |
| PLAY Dave & Buster's Entertainmen | New | 1.11% | +1.11 |
| ATMU Atmus Filtration Technologie | New | 1.08% | +1.08 |
| FLR Fluor Corp. | Add +72.2% | 3.25% | +1.04 |
| SDGR Schrodinger Inc. | New | 0.80% | +0.80 |
| CAR Avis Budget Group Inc. | New | 0.78% | +0.78 |
| QDEL Quidelortho Corp. | Add +144.9% | 3.40% | +0.71 |
| CHRS Coherus Oncology Inc. | Add +2531.5% | 0.73% | +0.69 |
| MATV Mativ Holdings Inc. | Add +49.1% | 2.22% | +0.69 |
| SWTX Springworks Therapeutics Inc. | New | 0.62% | +0.62 |
| NUVL Nuvalent Inc. Class A | New | 0.58% | +0.58 |
| CNNE Cannae Holdings Inc. | Add +234.5% | 0.80% | +0.53 |
| ADPT Adaptive Biotechnologies | Add +266.8% | 1.00% | +0.47 |
| XPER Xperi Inc. | Add +58.2% | 1.44% | +0.39 |
| MD Pediatrix Medical Group Inc. | New | 0.27% | +0.27 |
| CSTM Constellium SE | Add +24.1% | 2.37% | +0.20 |
| OPK Opko Health Inc. | New | 0.18% | +0.18 |
| PTGX Protagonist Therapeutics Inc. | New | 0.17% | +0.17 |
| CRS Carpenter Technology | New | 0.17% | +0.17 |
| XERS Xeris Biopharma Holdings Inc. | New | 0.02% | +0.02 |
| MYPS Playstudios Inc. | Add +20.8% | 0.19% | −0.00 |
| LBTYA Liberty Global Ltd. Class A | Add +29.1% | 1.92% | −0.05 |
| RVNC Revance Therapeutics Inc. | Add +81.8% | 0.39% | −0.09 |
| AMRX Amneal Pharmaceuticals Inc. | Add +19.3% | 1.71% | −0.10 |
| PTVE Pactiv Evergreen Inc. | Add +9.9% | 2.35% | −0.23 |
| DOLE Dole PLC | Add +13.5% | 1.81% | −0.26 |
| SCPH Scpharmaceuticals Inc. | Add +0.7% | 0.52% | −0.30 |
| LBTYK Liberty Global Ltd. Class C | Add +2.2% | 0.99% | −0.30 |
| SSYS Stratasys Ltd. | Add +18.8% | 1.74% | −0.53 |
| VYX NCR Voyix Corp. | Add +26.6% | 1.70% | −0.57 |
| VTRS Viatris Inc. | Add +5.0% | 6.51% | −0.59 |
| RNW Renew Energy Global PLC-A | Add +12.4% | 2.08% | −0.90 |
| ROIV Roivant Sciences Ltd. | Add +5.3% | 6.23% | −1.73 |
Options Activity Q4 2023 → Q1 2024
| SPY SS SPDR S&P 500 ETF Trust-US | put | Sold out | 4,500,000 | $2.1Bbefore exit |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
Notes & Other Activity Q4 2023 → Q1 2024
| COHERUS ONCOLOGY INC (CHRS 1.5 04/15/26) | NOTE 1.500% 4/1 · principal | Add +400.0% | 2,500,000 | $1.6M |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 86 | $10.9B | TLN, FTAI, VTRS, TEVA, GLNG |
| Q1 2026 | 81 | $8.2B | TLN, FTAI, GLNG, TEVA, VTRS |
| Q4 2025 | 75 | $8.4B | TLN, FTAI, TEVA, GLNG, VST |
| Q3 2025 | 69 | $7.4B | TLN, FTAI, TEVA, GLNG, ROIV |
| Q2 2025 | 62 | $6.2B | TLN, TEVA, FTAI, GLNG, VST |
| Q1 2025 | 64 | $5.6B | TLN, TEVA, GLNG, FTAI, QDEL |
| Q4 2024 | 66 | $5.5B | TLN, TEVA, GLNG, VTRS, QDEL |
| Q3 2024 | 62 | $6.1B | TLN, TEVA, ROIV, VST, GLNG |
| Q2 2024 | 66 | $3.8B | TEVA, ROIV, VTRS, GLNG, BGC |
| Q1 2024 | 67 | $3.4B | TEVA, VTRS, ROIV, GLNG, BGC |